• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用磁共振成像衍生的质子密度脂肪分数图进行全肝脂肪自动定量:台湾的一项前瞻性研究。

Automated Whole-Liver Fat Quantification with Magnetic Resonance Imaging-Derived Proton Density Fat Fraction Map: A Prospective Study in Taiwan.

作者信息

Wu Chih-Horng, Yen Kuang-Chen, Wang Li-Ying, Hsieh Ping-Lun, Wu Wei-Kai, Lee Pei-Lin, Liu Chun-Jen

机构信息

Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.

Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Gut Liver. 2025 Jul 15;19(4):617-626. doi: 10.5009/gnl240408. Epub 2025 Apr 1.

DOI:10.5009/gnl240408
PMID:40169393
Abstract

BACKGROUND/AIMS: Magnetic resonance imaging (MRI) with a proton density fat fraction (PDFF) sequence is the most accurate, noninvasive method for assessing hepatic steatosis. However, manual measurement on the PDFF map is time-consuming. This study aimed to validate automated whole-liver fat quantification for assessing hepatic steatosis with MRI-PDFF.

METHODS

In this prospective study, 80 patients were enrolled from August 2020 to January 2023. Baseline MRI-PDFF and magnetic resonance spectroscopy (MRS) data were collected. The analysis of MRI-PDFF included values from automated whole-liver segmentation (autoPDFF) and the average value from measurements taken from eight segments (avePDFF). Twenty patients with ≥10% autoPDFF values who received 24 weeks of exercise training were also collected for the chronologic evaluation. The correlation and concordance coefficients (r and ρ) among the values and differences were calculated.

RESULTS

There were strong correlations between autoPDFF versus avePDFF, autoPDFF versus MRS, and avePDFF versus MRS (r=0.963, r=0.955, and r=0.977, all p<0.001). The autoPDFF values were also highly concordant with the avePDFF and MRS values (ρ=0.941 and ρ=0.942). The autoPDFF, avePDFF, and MRS values consistently decreased after 24 weeks of exercise. The change in autoPDFF was also highly correlated with the changes in avePDFF and MRS (r=0.961 and r=0.870, all p<0.001).

CONCLUSIONS

Automated whole-liver fat quantification might be feasible for clinical trials and practice, yielding values with high correlations and concordance with the time-consuming manual measurements from the PDFF map and the values from the highly complex processing of MRS (ClinicalTrials.gov identifier: NCT04463667).

摘要

背景/目的:采用质子密度脂肪分数(PDFF)序列的磁共振成像(MRI)是评估肝脂肪变性最准确的非侵入性方法。然而,在PDFF图上进行手动测量很耗时。本研究旨在验证利用MRI-PDFF进行全肝脂肪自动定量以评估肝脂肪变性的方法。

方法

在这项前瞻性研究中,2020年8月至2023年1月纳入了80例患者。收集了基线MRI-PDFF和磁共振波谱(MRS)数据。MRI-PDFF分析包括自动全肝分割值(autoPDFF)和八个节段测量的平均值(avePDFF)。还收集了20例autoPDFF值≥10%且接受了24周运动训练的患者进行时间序列评估。计算了各值之间的相关性和一致性系数(r和ρ)以及差异。

结果

autoPDFF与avePDFF、autoPDFF与MRS、avePDFF与MRS之间均存在强相关性(r = 0.963、r = 0.955和r = 0.977,均p < 0.001)。autoPDFF值与avePDFF和MRS值也高度一致(ρ = 0.941和ρ = 0.942)。运动24周后,autoPDFF、avePDFF和MRS值持续下降。autoPDFF的变化与avePDFF和MRS的变化也高度相关(r = 0.961和r = 0.870,均p < 0.001)。

结论

全肝脂肪自动定量在临床试验和实践中可能是可行的,其结果与从PDFF图进行的耗时手动测量值以及MRS高度复杂处理得到的值具有高度相关性和一致性(ClinicalTrials.gov标识符:NCT04463667)。

相似文献

1
Automated Whole-Liver Fat Quantification with Magnetic Resonance Imaging-Derived Proton Density Fat Fraction Map: A Prospective Study in Taiwan.利用磁共振成像衍生的质子密度脂肪分数图进行全肝脂肪自动定量:台湾的一项前瞻性研究。
Gut Liver. 2025 Jul 15;19(4):617-626. doi: 10.5009/gnl240408. Epub 2025 Apr 1.
2
Diagnostic Performance of Ultrasound-Based Liver Fat Quantification With Reference to Magnetic Resonance Imaging Proton Density Fat Fraction and Histology.基于超声的肝脏脂肪定量相对于磁共振成像质子密度脂肪分数和组织学的诊断性能
J Clin Ultrasound. 2025 Apr 15. doi: 10.1002/jcu.24010.
3
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study.以基于磁共振成像的质子密度脂肪分数为参考标准,比较衰减成像与受控衰减参数对肝脂肪变性的诊断性能:一项前瞻性多中心研究。
J Gastroenterol. 2025 Jun;60(6):727-737. doi: 10.1007/s00535-025-02224-0. Epub 2025 Feb 24.
4
Attenuation Coefficient for Hepatic Steatosis Using a Single Ultrasound System: Associations of Measurement Parameters With Interoperator Agreement and Diagnostic Performance.使用单一超声系统测量肝脂肪变性的衰减系数:测量参数与不同操作者间一致性及诊断性能的关联
AJR Am J Roentgenol. 2025 Jun;224(6):e2532746. doi: 10.2214/AJR.25.32746. Epub 2025 Jun 25.
5
The diagnostic value of MRI-PDFF in hepatic steatosis of patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.MRI-PDFF对代谢功能障碍相关脂肪性肝病患者肝脂肪变性的诊断价值:一项系统评价和荟萃分析
BMC Gastroenterol. 2025 Jul 1;25(1):451. doi: 10.1186/s12876-025-04017-4.
6
Liver and pancreatic fat fractions as predictors of disease severity in acute pancreatitis: an MRI IDEAL-IQ study.肝脏和胰腺脂肪分数作为急性胰腺炎疾病严重程度的预测指标:一项MRI IDEAL-IQ研究
Abdom Radiol (NY). 2025 Jan 30. doi: 10.1007/s00261-025-04809-y.
7
MRI-PDFF Assessment of Intrahepatic Fat Changes Post-Bariatric Surgery: A Systematic Literature Review.减重手术后肝内脂肪变化的MRI-PDFF评估:一项系统文献综述
Medicina (Kaunas). 2024 Dec 4;60(12):2003. doi: 10.3390/medicina60122003.
8
A fasting-mimicking diet programme reduces liver fat and liver inflammation/fibrosis measured by magnetic resonance imaging in patients with type 2 diabetes.一项模拟禁食饮食方案可减少2型糖尿病患者肝脏脂肪以及通过磁共振成像测量的肝脏炎症/纤维化。
Clin Nutr. 2025 Apr;47:136-145. doi: 10.1016/j.clnu.2025.02.017. Epub 2025 Feb 18.
9
Enhanced accuracy and stability in automated intra-pancreatic fat deposition monitoring of type 2 diabetes mellitus using Dixon MRI and deep learning.使用狄克逊磁共振成像(Dixon MRI)和深度学习提高2型糖尿病胰腺内脂肪沉积自动监测的准确性和稳定性。
Abdom Radiol (NY). 2025 Jan 22. doi: 10.1007/s00261-025-04804-3.
10
In-vivo liver proton density fat fraction quantification at 0.55 T: a pilot study with comparison against 3 T MRI.0.55T下肝脏质子密度脂肪分数的活体定量:一项与3T MRI对比的初步研究。
MAGMA. 2025 Jul 15. doi: 10.1007/s10334-025-01277-9.

本文引用的文献

1
Precision and Robust Models on Healthcare Institution Federated Learning for Predicting HCC on Portal Venous CT Images.基于门静脉 CT 图像预测 HCC 的医疗保健机构联邦学习的精准稳健模型。
IEEE J Biomed Health Inform. 2024 Aug;28(8):4674-4687. doi: 10.1109/JBHI.2024.3400599. Epub 2024 Aug 6.
2
Automated liver volumetry and hepatic steatosis quantification with magnetic resonance imaging proton density fat fraction.利用磁共振成像质子密度脂肪分数进行肝脏体积自动测量和肝脂肪变性定量分析。
J Formos Med Assoc. 2025 Mar;124(3):264-270. doi: 10.1016/j.jfma.2024.04.012. Epub 2024 Apr 20.
3
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease.
代谢相关脂肪性肝病:新命名对美国肝病研究学会非酒精性脂肪性肝病实践指南的影响及更新。
Hepatology. 2024 May 1;79(5):1212-1219. doi: 10.1097/HEP.0000000000000670. Epub 2023 Nov 9.
4
Automated 3D liver segmentation from hepatobiliary phase MRI for enhanced preoperative planning.基于肝胆期 MRI 的肝脏自动三维分割用于增强术前规划。
Sci Rep. 2023 Oct 17;13(1):17605. doi: 10.1038/s41598-023-44736-w.
5
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
6
Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.用于鉴别CT诊断的代谢功能障碍相关脂肪性肝病的脂肪变性指数诊断性能比较
Metabolites. 2022 Jul 19;12(7):664. doi: 10.3390/metabo12070664.
7
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.非酒精性脂肪性肝病和肝纤维化中的内脏脂肪指数——系统评价与荟萃分析
Biomedicines. 2021 Dec 13;9(12):1890. doi: 10.3390/biomedicines9121890.
8
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.自动化全肝 MRI 分割以评估慢性肝病中的脂肪变性和铁定量。
Radiology. 2022 Feb;302(2):345-354. doi: 10.1148/radiol.2021211027. Epub 2021 Nov 16.
9
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
10
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:通过饮食和运动来实现减肥以治疗非酒精性脂肪性肝病的生活方式干预:专家综述。
Gastroenterology. 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9.